EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)

Kelly E Craven, Mark D Ewalt

Clinics in Laboratory Medicine · 2023

DOI: 10.1016/j.cll.2023.06.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2023. Verfasst von Kelly E Craven und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Hematologic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premalignant clonal hematopoiesis is the presence of somatic alterations in the blood of otherwise healthy individuals. Although the condition is not considered as a cancer, it carries an increased risk of developing a hematologic malignancy, particularly in those with large neoplastic clones, multiple pathogenic mutations, and high-risk mutations. In addition to the increased risk of malignancy, clonal hematopoiesis carries a markedly increased risk of cardiovascular events and death. Appropriate identification of this entity is critical to mitigate cardiovascular risk factors and ensure appropriate monitoring for the emergence of blood cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisHematologic NeoplasmsHumansHematopoiesisMutationClone Cells

Stichwörter der Autor:innen

Clonal cytopenia of undetermined significanceClonal hematopoiesisClonal hematopoiesis of indeterminate potentialParoxysmal nocturnal hemoglobinuriaTherapy-related clonal hematopoiesisVEXAS syndrome

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA. Electronic address: ewaltm@mskcc.org.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Craven, K. E., & Ewalt, M. D. (2023). Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance). Clinics in Laboratory Medicine. https://doi.org/10.1016/j.cll.2023.06.001

Vancouver

Craven KE, Ewalt MD. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance). Clinics in Laboratory Medicine. 2023. doi:10.1016/j.cll.2023.06.001

BibTeX
@article{Craven2023,
  author = {Craven, Kelly E and Ewalt, Mark D},
  title = {Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)},
  journal = {Clinics in Laboratory Medicine},
  year = {2023},
  doi = {10.1016/j.cll.2023.06.001}
}
Kostenlos starten →